GRIMALDI, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 2.000
NA - Nord America 1.571
EU - Europa 1.335
SA - Sud America 219
AF - Africa 64
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 5.194
Nazione #
US - Stati Uniti d'America 1.486
SG - Singapore 821
RU - Federazione Russa 581
CN - Cina 416
VN - Vietnam 377
IT - Italia 285
BR - Brasile 187
HK - Hong Kong 126
DE - Germania 93
FR - Francia 74
GB - Regno Unito 58
NL - Olanda 54
FI - Finlandia 49
IN - India 49
BD - Bangladesh 48
CA - Canada 47
JP - Giappone 44
IE - Irlanda 30
KR - Corea 30
CI - Costa d'Avorio 24
SE - Svezia 22
UA - Ucraina 22
MX - Messico 21
ZA - Sudafrica 17
AR - Argentina 15
AT - Austria 14
PL - Polonia 14
IQ - Iraq 13
ES - Italia 10
LT - Lituania 10
PH - Filippine 10
PK - Pakistan 9
TH - Thailandia 9
ID - Indonesia 7
TR - Turchia 7
EC - Ecuador 6
JM - Giamaica 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
CZ - Repubblica Ceca 5
KE - Kenya 5
BE - Belgio 4
MY - Malesia 4
TW - Taiwan 4
UZ - Uzbekistan 4
CH - Svizzera 3
HN - Honduras 3
IL - Israele 3
MA - Marocco 3
NP - Nepal 3
AO - Angola 2
AU - Australia 2
AZ - Azerbaigian 2
BO - Bolivia 2
CR - Costa Rica 2
DZ - Algeria 2
EU - Europa 2
JO - Giordania 2
KW - Kuwait 2
KZ - Kazakistan 2
PY - Paraguay 2
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
CO - Colombia 1
CW - ???statistics.table.value.countryCode.CW??? 1
EG - Egitto 1
GA - Gabon 1
HR - Croazia 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MG - Madagascar 1
ML - Mali 1
MR - Mauritania 1
MU - Mauritius 1
MW - Malawi 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
YE - Yemen 1
Totale 5.194
Città #
Singapore 409
San Jose 222
Ashburn 159
Moscow 156
Hefei 134
Chandler 124
Hong Kong 119
Ho Chi Minh City 104
Beijing 90
Naples 82
Hanoi 75
Santa Clara 67
Los Angeles 56
Lauterbourg 41
The Dalles 41
Council Bluffs 38
New York 38
Tokyo 37
Amsterdam 36
Millbury 34
Munich 30
Dong Ket 28
Seoul 23
Napoli 22
Des Moines 19
Da Nang 18
Princeton 18
Redondo Beach 18
Frankfurt am Main 17
Boston 16
Buffalo 16
Milan 16
Nanjing 16
Dallas 15
São Paulo 15
Helsinki 13
Rome 13
Stockholm 13
Turku 13
Denver 12
Haiphong 12
London 12
Montreal 12
Brooklyn 11
Kochi 11
Ottawa 11
Lawrence 10
Seattle 10
Toronto 10
Warsaw 10
Orem 9
Chennai 8
Houston 8
Poplar 8
Redwood City 8
Chicago 7
Falkenstein 7
Johannesburg 7
Lappeenranta 7
Mexico City 7
Nanchang 7
Nuremberg 7
Phoenix 7
Porto Alegre 7
Wilmington 7
Atlanta 6
Bình Phước 6
Dublin 6
New Delhi 6
Rio de Janeiro 6
San Francisco 6
Baghdad 5
Campagna 5
Changsha 5
Dhaka 5
Florence 5
Querétaro 5
Quito 5
Shenyang 5
Tianjin 5
Vienna 5
Brasília 4
Brussels 4
Bến Tre 4
Cape Town 4
Hamilton 4
Istanbul 4
Manchester 4
Nairobi 4
Norwalk 4
Queens 4
Salvador 4
Tashkent 4
Ankara 3
Aracaju 3
Bangkok 3
Bengaluru 3
Birmingham 3
Biên Hòa 3
Bắc Ninh 3
Totale 2.788
Nome #
A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison 186
Intravascular Complications of Central Venous Catheterization by Insertion Site in Acute Leukemia during Remission Induction Chemotherapy Phase: Lower Risk with Peripherally Inserted Catheters in a Single-Center Retrospective Study 176
(1-3)-β-d-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations 175
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study 151
Fine needle aspiration cytology and flow cytometry immunophenotyping of non-Hodgkin lymphoma: can we do better?. 149
JAK2V617F mutation persists in blasts and mature cells of transformed JAK2V617F-positive-myeloproliferative neoplasia: a European Leukemia Net (ENL) study. 143
XM02 PLUS CHEMOTHERAPY IS SAFE AND EFFECTIVE IN STEM CELL MOBILIZATION FOR PATIENTS CANDIDATED TO AUTOLOGOUS STEM CELL TRANSPLANTATION 141
LONG-TERM FOLLOW UP OF ALENTUZUMAB-BASED IMMUNOSUPPRESSION FOR THE TREATMENT OF IMMUNE-MEDIATED BONE MARROW FAILURE SYNDROMES 139
Acute immune toxicity during anti-thymocyte globulin: That's CARPA! 139
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis 139
Myeloid Sarcoma of the Breast as Blast Phase of JAK2-Mutated (Val617Phe Exon 14p) Essential Thrombocythemia: A Case Report and a Systematic Literature Review 133
PEG-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION : A SINGLE-CENTRE EXPERIENCE 133
Twenty years of the Italian Fanconi Anemia Registry: Where we stand and what remains to be learned 133
Contrast-enhanced harmonic compound US of the spleen to increase staging accuracy in patients with Hodgkin lymphoma: a prospective study. 132
PEGYLATED-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION: SINGLE CENTRE EXPERIENCE 132
Excellent outcome of concomitant intensive immunosuppression and eculizumab in aplastic anemia/paroxysmal nocturnal hemoglobinuria syndrome. 131
THIOTEPA AND MELPHALAN AS NEW CONDITIONING REGIMEN FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE LYELOMA 131
Retroperitoneal extramedullary relapse after blinatumomab in acute lymphoblastic leukemia failing haplo-identical bone marrow transplantation. 126
1139 poster ASYMPTOMATIC HEART DISEASE AFTER MEDIASTINAL IRRADIATION IN HODGKIN'S LYMPHOMA: PRELIMINARY FINDINGS 125
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients 123
Thyroid V30 Predicts Radiation-Induced Hypothyroidism in Patients Treated With Sequential Chemo-Radiotherapy for Hodgkin’s Lymphoma 122
Fine needle aspiration cytology and flow cytometry immunophenotyping of non-Hodgkin lymphoma: can we do better? 117
Efficacy and safety of rituximab treatment in patients with progressive transformation of germinal centers after Hodgkin lymphoma in complete remission post-induction chemotherapy and radiotherapy. 114
Deregulation of New Cell Death Mechanisms in Leukemia 113
Long-term Cryopreserved Autologous Hematopoietic Stem Cells Following Azacytidine to Successfully Treat Severe Invasive Pulmonary Aspergillosis After Therapy-Related Myelodysplastic Syndrome and CD8+ T-cell Autoimmune Disorders: A Case Report 112
Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen. 112
Molecular analysis of T-cell Acute Lymphoblastic Leukemia arising after Essential Thrombocythemia foreshadows a distinct clonal route for lymphoid blast crisis in Philadelphia-negative chronic myeloproliferative neoplasm: a case report with literary review 109
New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemia 109
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias 106
COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL report 105
Epidemiology of Acquired Bone Marrow Failure 105
Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients 103
Caspofungin for Primary Antifungal Prophylaxis in Acute Myeloid Leukemia: A Real-Life Study from an Academic Center 101
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study 99
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years 88
Up-front Blinatumomab Improves MRD Clearance and Outcome in Adult Ph- B-lineage ALL: the GIMEMA LAL2317 Phase 2 Study 84
Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy 80
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program 79
Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T Cells 74
Nonmyeloablative Peripheral Blood Haploidentical Stem Cell Transplantation for Refractory Severe Aplastic Anemia 68
Long-term real world evidence of CPX-351 of high-risk AML patients identified high rate of negative MRD and prolonged OS 67
Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI) 65
Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study 62
Luspatercept treatment affects immune-regulatory subsets in patients with MDS with ring sideroblasts 57
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study 56
Gallbladder Myeloid Sarcoma Associated With NPM1 Mutated Acute Myeloid Leukemia 53
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study 51
Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia 33
Totale 5.281
Categoria #
all - tutte 15.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022213 3 4 2 2 3 7 3 4 26 20 69 70
2022/2023295 28 14 10 9 52 42 2 38 52 31 13 4
2023/2024155 5 33 13 7 8 19 5 32 0 0 24 9
2024/20251.347 35 36 25 22 39 91 153 111 73 152 493 117
2025/20262.923 311 243 337 320 538 81 252 172 298 211 98 62
2026/202741 41 0 0 0 0 0 0 0 0 0 0 0
Totale 5.281